Combined Professional Program


October 2, 2021

8:00 AM - 12:00 PM CST 

 

Chairpersons

Chair: Joel Pekow, MD The University of Chicago Medicine

Co-Chair: Andres Yarur, MD, Froedtert & the Medical College of Wisconsin

 

This activity has been approved for AMA PRA Category 1 Credit(s)™.

8:00 am  Overview & Introduction

Russell Cohen, MD, The University of Chicago Medicine;  Eugene Yen, MD, NorthShore University HealthSystem; Joel Pekow, MD, The University of Chicago Medicine; Andres Yarur, MD, Froedtert & the Medical College of Wisconsin

Session 1: Utilizing new therapies in your practice

Moderator: Joel Pekow, MD


8:10 am

Using small molecules in IBD

Stephen Hanauer, MD, Northwestern Medicine


8:40 am

Small Molecules…small risks? Safety of S1P1 receptor modulators and JAK inhibitors

David Rubin, MD, The University of Chicago Medicine 


9:10 am

Treat to target: goals of therapy

Andres Yarur, MD, Froedtert & Medical College of Wisconsin


9:30 am

C. difficile therapies in 2021

Byron Vaughn, MD, The University of Minnesota School of Medicine


10:00 am

Q & A Session Panel


10:15 am 

Break and Visit Exhibits


Session 2: How has the management of IBD changed in the last year?

Moderator: Andres Yarur, MD


10:30 am 

Vaccines in immunosuppression – who, what, and when?

Parakkal Deepak, MD, Washington University School of Medicine


11:00 am

Treating IBD in the COVID era, what has changed?

Russell Cohen, MD, The University of Chicago Medicine  


11:30 am 

Precision Medicine in IBD, when and how?

Amar Naik, MD, Loyola Medicine


12:00 pm

Q & A Session Panel


12:15 pm

Visit Exhibits


12:30 pm

Lunch


AFTERNOON SESSION BREAKOUTS 

1:00 pm - 3:00 pm


Agenda subject to change

This activity has been designed to meet the educational needs of physicians involved in the care of patients with inflammatory bowel disease.​

0